Metabolites of ginsenosides as novel BCRP inhibitors
- 14 July 2006
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 345 (4) , 1308-1314
- https://doi.org/10.1016/j.bbrc.2006.04.152
Abstract
No abstract availableKeywords
Funding Information
- Association for International Cancer Research
This publication has 21 references indexed in Scilit:
- Arginine-482 is not essential for transport of antibiotics, primary bile acids and unconjugated sterols by the human breast cancer resistance protein (ABCG2)Biochemical Journal, 2005
- Modulating AngiogenesisCirculation, 2004
- Interaction of the breast cancer resistance protein with plant polyphenolsBiochemical and Biophysical Research Communications, 2004
- A molecular view of stem cell and cancer cell self-renewalThe International Journal of Biochemistry & Cell Biology, 2003
- Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2)Oncogene, 2003
- Breast Cancer Resistance Protein Exports Sulfated Estrogens but Not Free EstrogensMolecular Pharmacology, 2003
- Sterol Transport by the Human Breast Cancer Resistance Protein (ABCG2) Expressed in Lactococcus lactisPublished by Elsevier ,2003
- Reversal of P-Glycoprotein-Mediated Multidrug Resistance by Protopanaxatriol Ginsenosides from Korean Red GinsengPlanta Medica, 2003
- Characterization of Drug Transport, ATP Hydrolysis, and Nucleotide Trapping by the Human ABCG2 Multidrug TransporterPublished by Elsevier ,2002
- Estrone and 17β‐Estradiol Reverse Breast Cancer Resistance Protein‐mediated Multidrug ResistanceJapanese Journal of Cancer Research, 2002